304 related articles for article (PubMed ID: 22399364)
1. Local staging of prostate cancer with MRI.
Soylu FN; Eggener S; Oto A
Diagn Interv Radiol; 2012; 18(4):365-73. PubMed ID: 22399364
[TBL] [Abstract][Full Text] [Related]
2. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
Franiel T
Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
[TBL] [Abstract][Full Text] [Related]
3. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
Durmus T; Baur A; Hamm B
Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?
Iwazawa J; Mitani T; Sassa S; Ohue S
Diagn Interv Radiol; 2011 Sep; 17(3):243-8. PubMed ID: 20859852
[TBL] [Abstract][Full Text] [Related]
6. MR imaging and MR spectroscopy in prostate cancer management.
Katz S; Rosen M
Radiol Clin North Am; 2006 Sep; 44(5):723-34, viii. PubMed ID: 17030223
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric magnetic resonance imaging of the prostate: technical aspects and role in clinical management.
Costa DN; Pedrosa I; Roehrborn C; Rofsky NM
Top Magn Reson Imaging; 2014 Aug; 23(4):243-57. PubMed ID: 25099562
[TBL] [Abstract][Full Text] [Related]
8. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
[TBL] [Abstract][Full Text] [Related]
9. The expanding role of MRI in prostate cancer.
Murphy G; Haider M; Ghai S; Sreeharsha B
AJR Am J Roentgenol; 2013 Dec; 201(6):1229-38. PubMed ID: 24261361
[TBL] [Abstract][Full Text] [Related]
10. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
[TBL] [Abstract][Full Text] [Related]
11. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.
Kara T; Akata D; Akyol F; Karçaaltıncaba M; Özmen M
Diagn Interv Radiol; 2011 Mar; 17(1):38-43. PubMed ID: 20703995
[TBL] [Abstract][Full Text] [Related]
12. Role of high-field MR in studies of localized prostate cancer.
Lagemaat MW; Scheenen TW
NMR Biomed; 2014 Jan; 27(1):67-79. PubMed ID: 23703839
[TBL] [Abstract][Full Text] [Related]
13. Update of prostate magnetic resonance imaging at 3 T.
Kim CK; Park BK
J Comput Assist Tomogr; 2008; 32(2):163-72. PubMed ID: 18379296
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.
Delongchamps NB; Rouanne M; Flam T; Beuvon F; Liberatore M; Zerbib M; Cornud F
BJU Int; 2011 May; 107(9):1411-8. PubMed ID: 21044250
[TBL] [Abstract][Full Text] [Related]
16. High-field magnetic resonance imaging of the pelvis: uterus, ovary, and prostate gland.
Winter LM; Sommer G; Bongartz G
Top Magn Reson Imaging; 2010 Jun; 21(3):177-88. PubMed ID: 21847037
[TBL] [Abstract][Full Text] [Related]
17. Imaging prostate cancer.
Jung AJ; Westphalen AC
Radiol Clin North Am; 2012 Nov; 50(6):1043-59. PubMed ID: 23122037
[TBL] [Abstract][Full Text] [Related]
18. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
[TBL] [Abstract][Full Text] [Related]
19. Imaging of recurrent prostate cancer.
Fütterer JJ
Radiol Clin North Am; 2012 Nov; 50(6):1075-83. PubMed ID: 23122039
[TBL] [Abstract][Full Text] [Related]
20. [Staging and tissue characterization of prostate carcinoma: role of endorectal MR imaging and MR spectroscopy].
Sugimura K
Hinyokika Kiyo; 2000 Nov; 46(11):855-9. PubMed ID: 11193312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
